Gefter; Malcolm L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gefter; Malcolm L..The latest application filed is for "structural support scheme for the replacement of trailing portions of sails".

Company Profile

0.37.45

Gefter; Malcolm L. - Lincoln MA US
Gefter; Malcolm L. - Weston MA
Gefter; Malcolm L. - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Structural Support Scheme for the Replacement of Trailing Portions of Sails App 20140102346 - Gefter; Malcolm L.	2014-04-17
Methods for synthesis of encoded libraries Grant 8,598,089 - Morgan , et al. December 3, 2	2013-12-03
Methods for synthesis of encoded libraries Grant 8,410,028 - Morgan , et al. April 2, 2	2013-04-02
Methods For Synthesis Of Encoded Libraries App 20120245040 - Morgan; Barry ; et al.	2012-09-27
Methods For Identifying Compounds Of Interest Using Encoded Libraries App 20120071329 - Morgan; Barry ; et al.	2012-03-22
Pharmaceutical compositions for sustained drug delivery Grant 8,084,419 - Gefter December 27, 2	2011-12-27
Methods For Synthesis Of Encoded Libraries App 20110251089 - Morgan; Barry ; et al.	2011-10-13
Methods for identifying compounds of interest using encoded libraries Grant 7,989,395 - Morgan , et al. August 2, 2	2011-08-02
Methods for synthesis of encoded libraries Grant 7,972,994 - Morgan , et al. July 5, 2	2011-07-05
Methods for synthesis of encoded libraries Grant 7,972,992 - Morgan , et al. July 5, 2	2011-07-05
Methods For Synthesis Of Encoded Libraries App 20110136697 - MORGAN; Barry ; et al.	2011-06-09
Methods for synthesis of encoded libraries Grant 7,935,658 - Morgan , et al. May 3, 2	2011-05-03
Modulators Of Amyloid Aggregation App 20110009343 - Findeis; Mark A. ; et al.	2011-01-13
Methods And Compositions For Empirical Selection Of Drugs Or Other Molecules App 20100316998 - Gefter; Malcolm L.	2010-12-16
Hapten-carrier Conjugates For Use In Drug-abuse Therapy And Methods For Preparation Of Same App 20100209449 - Swain; Philip A. ; et al.	2010-08-19
Modulators of amyloid aggregation Grant 7,658,917 - Findeis , et al. February 9, 2	2010-02-09
Methods for synthesis of encoded libraries App 20090062147 - Morgan; Barry ; et al.	2009-03-05
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor Grant 7,482,008 - Gefter , et al. January 27, 2	2009-01-27
Methods for identifying compounds that bind to a target App 20080032896 - Benjamin; Howard ; et al.	2008-02-07
Modulators of beta-amyloid peptide aggregation comprising D-amino acids App 20070248996 - Findeis; Mark A. ; et al.	2007-10-25
Methods for identifying compounds of interest using encoded libraries App 20070224607 - Morgan; Barry ; et al.	2007-09-27
Pharmaceutical formulations for sustained drug delivery App 20070185033 - Gefter; Malcolm L. ; et al.	2007-08-09
Pharmaceutical formulations for sustained drug delivery App 20070185032 - Gefter; Malcolm L. ; et al.	2007-08-09
Methods for synthesis of encoded libraries App 20070042401 - Morgan; Barry ; et al.	2007-02-22
Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids Grant 7,175,828 - Findeis , et al. February 13, 2	2007-02-13
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060286099 - Swain; Philip A. ; et al.	2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060286098 - Swain; Philip A. ; et al.	2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060286095 - Swain; Philip A. ; et al.	2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060286096 - Swain; Philip A. ; et al.	2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060286097 - Swain; Philiip A. ; et al.	2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060280736 - Swain; Philip A. ; et al.	2006-12-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060280735 - Swain; Philip A. ; et al.	2006-12-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060239997 - Swain; Philip A. ; et al.	2006-10-26
Pharmaceutical compositions for sustained drug delivery App 20060094662 - Gefter; Malcolm L.	2006-05-04
Pharmaceutical compositions for sustained drug delivery Grant 7,037,889 - Gefter May 2, 2	2006-05-02
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20060058220 - Swain; Philip A. ; et al.	2006-03-16
Modulators of beta-amyloid peptide aggregation comprising D-amino acids App 20060014696 - Findeis; Mark A. ; et al.	2006-01-19
Methods for enhancing the bioavailability of a drug App 20050288222 - Hayward, Neil J. ; et al.	2005-12-29
Methods for synthesis of encoded libraries App 20050158765 - Morgan, Barry ; et al.	2005-07-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20050124061 - Swain, Philip A. ; et al.	2005-06-09
Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject App 20040265917 - Benjamin, Dennis ; et al.	2004-12-30
Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response Grant 6,759,234 - Gefter , et al. July 6, 2	2004-07-06
Methods for identifying compounds that bind to a target App 20040091904 - Benjamin, Howard ; et al.	2004-05-13
Pharmaceutical formulations for sustained drug delivery Grant 6,699,833 - Gefter , et al. March 2, 2	2004-03-02
Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids Grant 6,689,752 - Findeis , et al. February 10, 2	2004-02-10
Modulators of amyloid aggregation App 20040005307 - Findeis, Mark A. ; et al.	2004-01-08
Transcription factor modulators and uses thereof App 20030224992 - Joyal, John L. ; et al.	2003-12-04
Methods for identifying peptides which modulate a biological process App 20030175685 - Gefter, Malcolm L.	2003-09-18
Pharmaceutical formulations for sustained drug delivery App 20030171296 - Gefter, Malcolm L. ; et al.	2003-09-11
Methods For Identifying Compounds That Bind To A Target App 20030100007 - BENJAMIN, HOWARD ; et al.	2003-05-29
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20030069400 - Swain, Philip A. ; et al.	2003-04-10
Methods for enhancing the bioavailability of a drug App 20020142950 - Hayward, Neil J. ; et al.	2002-10-03
Therapeutic agents and methods of use thereof for treating an amyloidogenic disease App 20020133001 - Gefter, Malcolm L. ; et al.	2002-09-19
Modulators of beta-amyloid peptide aggregation comprising D-amino acids App 20020103134 - Findeis, Mark A. ; et al.	2002-08-01
Modulators of amyloid aggregation App 20020098173 - Findeis, Mark A. ; et al.	2002-07-25
Pharmaceutical compositions for sustained drug delivery App 20020086829 - Gefter, Malcolm L.	2002-07-04
Methods for treating sex hormone-dependent conditions with Lhrh antagonists Grant 6,384,017 - Garnick , et al. May 7, 2	2002-05-07
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same App 20020032316 - Swain, Philip A. ; et al.	2002-03-14
Modulators of amyloid aggregation Grant 6,319,498 - Findeis , et al. November 20, 2	2001-11-20
Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids Grant 6,303,567 - Findeis , et al. October 16, 2	2001-10-16
Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids Grant 6,277,826 - Findeis , et al. August 21, 2	2001-08-21
Methods for identifying compounds that bind to a target App 20010006778 - Benjamin, Howard ; et al.	2001-07-05
Peptide compounds useful for modulating FGF receptor activity Grant 6,214,795 - Benjamin , et al.	2001-04-10
Methods for treating LHRH associated disorders with LHRH antagonists Grant 6,211,153 - Garnick , et al. April 3, 2	2001-04-03
Methods for treating LHRH associated disorders with LHRH antagonists Grant 6,180,609 - Garnick , et al. January 30, 2	2001-01-30
Pharmaceutical formulations for sustained drug delivery Grant 6,180,608 - Gefter , et al. January 30, 2	2001-01-30
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor Grant 6,120,769 - Gefter , et al. September 19, 2	2000-09-19
Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids Grant 5,985,242 - Findeis , et al. November 16, 1	1999-11-16
Pharmaceutical formulations for sustained drug delivery Grant 5,968,895 - Gefter , et al. October 19, 1	1999-10-19
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same Grant 5,876,727 - Swain , et al. March 2, 1	1999-03-02
A.beta. peptides that modulate .beta.-amyloid aggregation Grant 5,854,204 - Findeis , et al. December 29, 1	1998-12-29
Modulators of .beta.-amyloid peptide aggregation Grant 5,854,215 - Findeis , et al. December 29, 1	1998-12-29
Methods for treating prostate cancer with LHRH antagonists Grant 5,843,902 - Garnick , et al. December 1, 1	1998-12-01
Methods for treating prostate cancer with LHRH-R antagonists Grant 5,780,435 - Garnick , et al. July 14, 1	1998-07-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same Grant 5,773,003 - Swain , et al. June 30, 1	1998-06-30
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same Grant 5,760,184 - Swain , et al. June 2, 1	1998-06-02
Chimeric antibodies Grant 5,169,939 - Gefter , et al. December 8, 1	1992-12-08
Immunonodulating compositions and their use Grant 5,019,384 - Gefter , et al. May 28, 1	1991-05-28
Ligand assay with one or two particulate reagents and filter Grant 4,459,361 - Gefter July 10, 1	1984-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.